Nasdaq Proc News Today

Procaps Group (NASDAQ:PROC – Get Free Report) and PureTech Health (NASDAQ:PRTC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Analyst Recommendations This is a breakdown of […]

Procaps Group S.A. (NASDAQ:PROC – Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 47,600 shares, an increase of 20.8% from the December 15th total of 39,400 shares. Based on an average daily trading volume, of 44,800 shares, the short-interest […]

Procaps Group (NASDAQ:PROC – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05, MarketWatch Earnings reports. The business had revenue of $118.41 million for the quarter, compared to the consensus estimate of $110.40 million. Procaps Group had a […]

Procaps Group (NASDAQ:PROC – Get Free Report) is set to announce its earnings results after the market closes on Tuesday, November 14th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Procaps Group (NASDAQ:PROC – Get Free Report) last announced its quarterly earnings results on Tuesday, September 5th. The company […]

Procaps Group S.A. (NASDAQ:PROC – Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 26,700 shares, a decline of 20.8% from the September 30th total of 33,700 shares. Currently, 0.1% of the shares of the company are sold short. Based […]

Procaps Group (NASDAQ:PROC – Get Rating) is one of 891 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Procaps Group to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, earnings, valuation and profitability. Profitability This table compares Procaps Group […]

Procaps Group (NASDAQ:PROC – Get Rating) posted its quarterly earnings data on Monday. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.11, reports. Procaps Group had a net margin of 8.01% and a negative return on equity of 233.90%. The company had revenue of $84.16 […]

Procaps Group S.A. (NASDAQ:PROC – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 103,600 shares, a drop of 14.2% from the April 30th total of 120,700 shares. Approximately 0.5% of the shares of the stock are short […]

Procaps Group S.A. (NASDAQ:PROC – Get Rating) – Investment analysts at Brookline Capital Management decreased their Q3 2023 earnings per share estimates for shares of Procaps Group in a research note issued to investors on Tuesday, May 16th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will earn $0.13 per share for […]

Procaps Group S.A. (NASDAQ:PROC – Get Rating) shares gapped up before the market opened on Monday . The stock had previously closed at $4.40, but opened at $4.81. Procaps Group shares last traded at $4.81, with a volume of 891 shares traded. Procaps Group Stock Down 0.5 % The firm’s fifty day simple moving average […]